دورية أكاديمية

Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer

التفاصيل البيبلوغرافية
العنوان: Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer
المؤلفون: Vergote, Ignace, Ray-Coquard, Isabelle, Anderson, Daniel M., Cantuaria, Guilherme, Colombo, Nicoletta, Garnier-Tixidre, Claire, Gilbert, Lucy, Harter, Philipp, Hettle, Robert, Lorusso, Domenica, Mäenpää, Johanna, Marth, Christian, Matsumoto, Koji, Ouwens, Mario, Poveda, Andrés, Raspagliesi, Francesco, Rhodes, Kirsty, Rubio Pérez, María J., Shapira-Frommer, Ronnie, Shikama, Ayumi, Sikorska, Magdalena, Moore, Kathleen, DiSilvestro, Paul
المصدر: In European Journal of Cancer November 2021 157:415-423
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09598049
DOI:10.1016/j.ejca.2021.08.023